Navigation Links
BMP Sunstone Receives High Tech Status
Date:1/5/2009

PLYMOUTH MEETING, Pa., Jan. 5 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP) ("BMP Sunstone" or the "Company"), today announced that Sunstone (Tangshan) Pharmaceutical Co., Ltd., has been granted high tech status in China's Hebei province. High tech status is awarded by the PRC to recognize companies that consistently invest in new product development and have substantial revenues generated by their own proprietary patented or innovative products. With this designation, BMP Sunstone is entitled to receive preferential tax treatment in 2008, including a tax refund of approximately $1.0 to $1.5 million to be recognized in the fourth quarter of 2008, as well as a preferential tax rate at 15 percent in 2009 and 2010. The preferential tax rate is notably lower than the Company's existing tax rate at 25 percent.

BMP Sunstone increased its non-GAAP net income guidance for the full year 2008 in order to account for the anticipated tax refund, and now expects non-GAAP net income to reach $6.0 to $7.0 million in 2008. This is an increase from prior full year 2008 expectations of $5.0 to $6.0 million. The Company continues to expect 2008 revenue in the range of $110 to $120 million.

David Gao, Chief Executive Officer of BMP Sunstone, stated "We are very glad to have our high tech status recognized because we'll realize a sizeable refund this year and lower our tax rate substantially to 15 percent for each of the next two years. As always, we will continue R&D investment to expand our product offering in addition to our product acquisition efforts so that we maintain extraordinary revenue and profit growth in the long-run."

Non-GAAP net income excludes stock based compensation, amortization related to acquisitions and other non-cash expenses.

About BMP Sunstone Corporation

BMP Sunstone Corporation is a specialty pharmaceutical company that is building a proprietary portfolio of branded pharmaceutical and healthcare products in China. Currently this portfolio includes eight products under exclusive multi-year licenses for China, primarily focused on women's health and pediatrics. The Company also owns Sunstone Pharmaceutical Co. Ltd., which manufactures leading pediatric and women's health products, including two of China's most recognized brands, "Hao Wawa" and "Confort," sold through approximately 50,000 pharmacies in China. The Company also provides pharmaceutical distribution services through its subsidiaries in Beijing and Shanghai, and through its affiliate, Guangzhou Pharmaceuticals Corp. The Company has its main office in Beijing, with a US office in Plymouth Meeting, PA. For more information, please visit http://www.bmpsunstone.com .

Safe Harbor Statement

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts, including but not limited to statements about the Company's revenue and non-GAAP net income guidance for 2008, current and future tax refunds and rates and incentives, and the Company's intent and ability to enhance its capabilities and realized additional opportunities. These statements are subject to uncertainties and risks including, but not limited to, operating performance, general financial, economic, and political conditions affecting the biotechnology and pharmaceutical industries and the Chinese pharmaceutical market, the ability to timely manufacture and distribute the Company's products and other risks contained in reports filed by the Company with the Securities and Exchange Commission. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

    For more information, please contact:

    BMP Sunstone Corporation
     Fred M. Powell
     Chief Financial Officer
     Tel:   +1-610-940-1675

    Integrated Corporate Relations, Inc.
     Ashley M. Ammon and Christine Duan
     Tel:   +1-203-682-8200 (Investor Relations)

'/>"/>
SOURCE BMP Sunstone Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. BMP Sunstone Receives SFDA Acceptance for Enablex(R) Clinical Trial
2. BMP Sunstone Receives Import Drug License (IDL) from SFDA
3. BMP Sunstone Corporation Appoints Zhiqiang Han to President and Chief Operating Officer
4. BMP Sunstone Reports Second Quarter 2008 Financial Results
5. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
6. BMP Sunstone Announces Participation in September Investor Conference
7. BMP Sunstone Announces Participation in November Investor Conferences
8. BMP Sunstone Reports Third Quarter 2008 Financial Results
9. BMP Sunstone to Host Follow-Up 3Q08 Conference Call Due to Technical Difficulties Encountered on Tuesdays Call
10. BMP Sunstone Acquires Runchang Capsule and Related LFHC Technology
11. BMP Sunstone to Present at the 20th Annual Piper Jaffray Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... While the ... such as the Cary 5000 and the 6000i models are higher end machines that ... the height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry Network ... Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s mission is ... projects are designed, built and brought to market. , The Design Lab is ...
Breaking Biology Technology:
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
(Date:3/22/2016)... PROVO and SANDY, Utah ... Ontario (NSO), which operates the highest sample volume laboratory ... and Tute Genomics and UNIConnect, leaders in clinical sequencing ... announced the launch of a project to establish the ... panel. NSO has been contracted by ...
Breaking Biology News(10 mins):